Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020

SELL
N/A
-229,347 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
N/A
160,500 Added 233.13%
229,347 $1.42 Million
Q4 2018

Feb 14, 2019

SELL
N/A
-3,993 Reduced 5.48%
68,847 $588,000
Q2 2018

Aug 14, 2018

SELL
N/A
-262,701 Reduced 78.29%
72,840 $1.88 Million
Q1 2018

May 15, 2018

BUY
N/A
254,256 Added 312.8%
335,541 $8.02 Million
Q4 2017

Feb 14, 2018

SELL
N/A
-682,642 Reduced 89.36%
81,285 $2.76 Million
Q3 2017

Nov 14, 2017

BUY
N/A
763,927
763,927 $16.2 Million

About Adamas Pharmaceuticals, Inc.


  • Ticker ADMS
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,408,100
  • Market Cap $376M
More about ADMS
Track This Portfolio

Track Kerrisdale Advisers, LLC Portfolio

Follow Kerrisdale Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kerrisdale Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kerrisdale Advisers, LLC with notifications on news.